Bristol Myers Squibb stock reports 6 percent Q2 revenue growth
Published on 10/03/2026 at 23:26 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Bristol Myers Squibb stock reported Q2 2026 revenue of USD 12.973 billion, up 6 percent year over year, while the shares closed at USD 61.15 on the NYSE on October 2, 2026. The latest quarterly figures put the drugmaker's growth portfolio against a valuation shaped by its mature product base and upcoming earnings date.
Q2 revenue reaches USD 12.973 billion
StockTitan reported that Bristol Myers Squibb generated USD 12.973 billion of revenue in Q2 2026, compared with USD 12.27 billion in the prior-year quarter. Net earnings attributable to Bristol Myers Squibb reached USD 3.317 billion, while GAAP diluted EPS rose to USD 1.62 from USD 0.64.
The earnings mix is important. Growth Portfolio revenue increased 15 percent to USD 7.560 billion, while the Legacy Portfolio declined 4 percent to USD 5.422 billion, according to StockTitan. Eliquis revenue reached USD 4.481 billion, up 22 percent, highlighting both the strength of the core franchise and the company's exposure to product-cycle risk.
Analyst target stands above USD 61.15
On October 2, 2026, MarketBeat reported a Moderate Buy consensus and an average price target of USD 67.06. That target lies 9.7 percent above the October 2 closing price of USD 61.15, a measurable gap that leaves the next earnings update as the key operational checkpoint.
The same MarketBeat report said quarterly adjusted EPS was USD 2.04 versus a USD 1.60 consensus estimate, while revenue reached USD 12.97 billion against expectations of USD 11.74 billion. Bristol Myers Squibb's fiscal 2026 adjusted EPS guidance stood at USD 6.750-7.000, and Zacks listed October 29, 2026, as the expected next earnings release date in its earnings calendar.
Stock stays below its yearly high
Bristol Myers Squibb closed at USD 61.15 on the NYSE on October 2, 2026. The price was USD 7.49 below the 52-week high of USD 68.64, equal to 10.91 percent, while the 52-week low stood at USD 42.52 and market capitalization at USD 124.9 billion.
Bristol Myers Squibb stock at a glance
- Company: Bristol-Myers Squibb Company
- ISIN: US1101221083
- Ticker: BMY
- Trading venue: NYSE
- Price (as of October 2, 2026): Closing price USD 61.15
- Market capitalization: USD 124.9 billion (as of October 2, 2026)
- 52-week range: USD 42.52-68.64 (as of October 2, 2026)
- Sector / Industry: Healthcare / Drug Manufacturers - General
